Analysis of hospital purchases of antimicrobial drugs in the framework of the pharmaceutical market the North-Western Federal District

Abstract

The results of the analysis of the hospital segment of the national and regional markets in the period from 2013 to 2017 are presented in the paper. It was established that volume of the Russian pharmaceutical market for hospital purchases grew by 42 % in value terms and by 8 % in physical terms over the study period. At the same time, the share of drugs represented by foreign manufacturers decreased by 5 % in value terms and by 2 % in physical terms, respectively. It has been established that in the given research conditions the group J «Antimicrobial drugs of systemic action» is the leader in the overall structure of national procurement, covering more than 30.0-35.5 % in value and more than 26.0-30.0 than 50 % of the range of antibacterial drugs. It is shown that in the structure of procurement, leading positions in terms of value were noted for foreign manufacturers, in natural units, domestic two producers play a leading role (more than 40 % of the assortment) both in the national and regional markets. At the same time, the vaccine for the prevention of pneumococcal infections (6-8 %) leads in cost terms, in natural units, ceftriaxone (about 20 %).